NK |
natural killer |
GBM |
glioblastoma |
BTZ |
bortezomib |
GM1 |
monosialotetrahexosylganglioside |
TMZ |
temozolomide |
HLA |
human leucocyte antigen |
KIR |
killer immunoglobulin-like receptor |
SHP-1/-2 |
Src-Homology 2 domain Phosphatase |
MICA/B |
MHC chain-related antigen |
ULBP |
UL16-binding protein |
TNF |
tumour necrosis factor |
IFN |
interferon |
TRAIL |
TNF-related apoptosis-inducing ligand |
DNAM-1 |
DNAX accessory molecule-1 |
ATP |
adenosine triphosphate |
IC50
|
Half maximal inhibitory concentration |
PARP-1 |
poly ADP-ribose polymerase-1 |
CQ |
chloroquine |
GFP |
green fluorescent protein |
MRI |
magnetic resonance imaging |
Mlc-1 |
myeloid leukaemia cell differentiation protein |
DMEM |
Dulbecco’s Modified Eagle’s medium |
FBS |
fetal bovine serum |
NEAA |
non-essential Amino Acid |
REK |
regional committees for medical and health research ethics |
NB |
Neural Basal medium |
PBMCs |
Peripheral blood mononuclear cells |
SC |
Stem Cell Growth Medium |
ELISA |
Enzyme-linked immunosorbent assay |
NHA |
normal human astrocytes |
E:T |
effector:target |
PBS |
phosphate-buffered saline |
IR |
infrared |
FMO |
fluorescent minus one |
DAPI |
4′,6-diamidino-2-phenylindole |
OCR |
oxygen consumption rate |
NOD/SCID |
non-obese diabetic/severe combined immunodeficiency |
H&E |
hematoxylin and eosin |
IHC |
immunohistochemistry |
SEM |
standard error of the mean |
ANOVA |
analysis of variance |
UiB |
University of Bergen |
PI |
propidium iodide |
MFI |
mean of fluorescence intensity |
IDH |
isocitrate dehydrogenase |